WearOptimo Unveils First Data on Wearable Hydration Sensor Technology, Outperforming Gold Standard Tests

Distinguished U.S. experts and global industry leaders have joined WearOptimo’s newly formed advisory board to drive strategic growth and innovation.
WearOptimo Introduces World-Class Advisory Board

Distinguished U.S. experts and global industry leaders have joined WearOptimo’s newly formed advisory board to drive strategic growth and innovation.
The backing of a proven sporting pedigree

WearOptimo is proud to count Mark Webber AO as an investor and strategic partner. The Formula 1 champion and endurance athlete came on board after meeting WearOptimo founder and CEO Professor Mark Kendall through a mutual association with luxury watch brand Rolex.
A critical conversation with Planet Hope

Cardiovascular disease is the biggest killer on the planet, claiming more than 30 million lives annually. It’s a horrifying statistic. One made even more so when you consider that all too often – especially with heart attacks – treatment could be as simple as taking an aspirin. If only the victim had more time to act.
Brisbane HealthTech starts Pilot Human Clinical Trials on a Microwearable Sensor

Pioneering Brisbane healthtech company WearOptimo has started clinical trials of its hydration sensor, marking a significant step in bringing this game-changing product to market.
No sweat as WearOptimo and Aspen Medical reach another milestone

Healthtech innovator WearOptimo and leading healthcare provider Aspen Medical have reached another significant milestone in the commercialisation of ground-breaking microwearable hydration sensors.
Aspen Medical has shown its further confidence in WearOptimo by following up its multi-million-dollar investment with the finalisation of a Strategic Collaboration Agreement and Distribution Framework Agreement.
Clinical trials get the green light

Human trials of a microwearable sensor for the detection of dangerous dehydration levels are set to begin after the latest successful fundraising round for HealthTech firm WearOptimo. The $5 million boost will enable the company to progress its game-changing hydration monitor, through clinical trials at QUT.
WearOptimo backed by Aspen Medical in multi-million-dollar strategic deal

A multi-million-dollar investment agreement by Aspen Medical in Queensland-based health-tech company WearOptimo, has cemented a strategic partnership between the two companies to revolutionise precision medicine globally.
Manufacturing project worth $3.9 million

We are very excited to share that WearOptimo has been awarded a $973,000 grant under the Australian Government’s Manufacturing Modernisation Fund (MMF) through the Department of Industry, Science, Energy and Resources.
$30 million manufacturing project

World-leading, lifesaving wearable medical technology will be produced at a new Queensland facility, supported by an up to $30 million project announced today.